Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Regulatory News (SHP)

  • There is currently no data for SHP

Rule 2.9 Announcement

14 Dec 2018 07:00



Rule 2.9 Announcement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

14 December 2018

Shire plc

(“Shire” or the “Company”)

Rule 2.9 Announcement

In accordance with Rule 2.9 of the City Code on Takeovers and Mergers, the Company confirms that, as at the close of business on 13 December 2018, being the last business day prior to the date of this announcement, it had 924,178,050 ordinary shares of 5 pence each in issue and admitted to trading on the main market of the London Stock Exchange. Shire holds 7,357,283 ordinary shares in treasury. Accordingly, the total number of voting rights in Shire is 916,820,767. The International Securities Identification Number (“ISIN”) for Shire’s ordinary shares is JE00B2QKY057.

Shire has an American Depositary Share (“ADS”) programme for which Citibank, N.A. acts as depositary. One ADS represents three ordinary shares of 5 pence each, with ISIN US82481R1068. The ADSs trade on the NASDAQ Global Select Market.

Enquiries:

Shire plc

Christoph Brackmann (Investor Relations) +41 41 288 4129Sun Kim (Investor Relations) +1 617 588 8175Katie Joyce (Media) +1 781 482 2779


Date   Source Headline
12th Dec 20189:49 amRNSForm 8.5 (EPT/RI)- Shire plc
12th Dec 20188:22 amBUSForm 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT
12th Dec 20188:22 amBUSForm 8.3 - SHIRE PLC - AMENDMENT
12th Dec 20187:27 amRNSForm 8.3 - Shire plc
12th Dec 20187:00 amRNSForm 8.3 - Shire Plc
12th Dec 20187:00 amGNWRule 2.9 Announcement
11th Dec 20184:07 pmRNSForm 8.5 (EPT/RI)- Shire plc AMENDMENT
11th Dec 20183:29 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
11th Dec 20183:29 pmRNSForm 8.3 - Shire plc
11th Dec 20183:23 pmRNSForm 8.5 (EPT/RI) - Replacement of Shire plc
11th Dec 20183:22 pmRNSForm 8.3 - Shire Plc
11th Dec 20183:20 pmRNSForm 8.3 - Shire plc
11th Dec 20183:20 pmGNWDavidson Kempner Capital Management LP : Form 8.3 - Shire Plc
11th Dec 20183:16 pmRNSForm 8.3 - Shire Plc
11th Dec 20183:14 pmRNSForm 8.5 (EPT/NON-RI)
11th Dec 20183:13 pmEQSForm 8.3 - The Vanguard Group, Inc.: Shire plc
11th Dec 20183:05 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
11th Dec 20182:48 pmRNSForm 8.5 (EPT/NON-RI)
11th Dec 20182:43 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
11th Dec 20182:43 pmRNSForm 8.3 - Shire plc
11th Dec 20182:26 pmPRNForm 8.3 - Shire Plc
11th Dec 20182:07 pmRNSForm 8.3 - Shire Plc
11th Dec 20181:59 pmBUSFORM 8.3 - SHIRE PLC
11th Dec 201812:10 pmRNSForm 8 (DD) - Citibank NA Jersey
11th Dec 201812:07 pmRNSForm 8 (DD) - Citibank NA London
11th Dec 201812:00 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited
11th Dec 201811:57 amRNSForm 8.3 - Shire plc
11th Dec 201811:55 amRNSForm 8.3 - Shire plc
11th Dec 201811:35 amRNSForm 8.5 (EPT/NON-RI)- Shire Plc
11th Dec 201811:35 amPRNForm 8.3 - Shire PLC
11th Dec 201811:28 amRNSForm 8.5 - Shire Plc
11th Dec 201811:23 amRNSForm 8.5 (EPT/RI) - Amendment
11th Dec 201811:21 amRNSForm 8.3 - Takeda Pharmaceutical
11th Dec 201811:20 amRNSForm 8.3 - Shire plc
11th Dec 201811:11 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
11th Dec 201811:10 amRNSForm 8.3 - Shire plc
11th Dec 201811:08 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
11th Dec 201811:06 amRNSForm 8.5 (EPT/RI)
11th Dec 201811:06 amRNSForm 8.5 (EPT/RI) - SHIRE PLC
11th Dec 201811:03 amRNSForm 8.3 - Takeda Pharmaceutical Company Limited
11th Dec 201810:59 amRNSForm 8.3 - Shire Plc
11th Dec 201810:51 amRNSForm 8.5 (EPT/NON-RI) - SHIRE PLC
11th Dec 201810:49 amRNSForm 8.5 (EPT/RI)- Shire plc
11th Dec 201810:49 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 201810:31 amRNSForm 8.5 (EPT/RI)
11th Dec 20189:26 amRNSForm 8 (DD) - Citibank NA London
11th Dec 20187:00 amRNSForm 8.3 - Shire PLC
11th Dec 20187:00 amGNWRule 2.9 Announcement
10th Dec 20184:21 pmBUSForm 8.3 - SHIRE PLC AMENDMENT
10th Dec 20183:33 pmRNSForm 8.3 - Takeda Pharmaceutical Company Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.